2382942-34-7
Chemical Structure
N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine
- CAS No.: 2382942-34-7
- Formula:C54H67N5O7
- Molecular Weight:898.14
IUPAC Name: N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(hexadecyloxy)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
InChIKey: RGWHAZWLGXZMBX-YNCYVDIXSA-N
SMILES: O[C@H]1[C@H]([C@H](N(C=N2)C3=C2C(NC(C4=CC=CC=C4)=O)=NC=N3)O[C@@H]1COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)OCCCCCCCCCCCCCCCC
Biological Activity: N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine | N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
